Home > Riviste > International Angiology > Fascicoli precedenti > International Angiology 2016 April;35(2) > International Angiology 2016 April;35(2):163-9

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLES   

International Angiology 2016 April;35(2):163-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

The efficacy of percutaneous transluminal angioplasty treatment for the patients with arteriovenous fistula dysfunction

Zhibing MING 1, Wendong LI 1, Wenbin DING 2, Ruifan YUAN 2, Xiaoqiang LI 1

1 Department of Vascular Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China; 2 Department of Intervention Radiology, The Second Affiliated Hospital of Nantong University, Nantong, China


PDF


BACKGROUND: The aim of this study was to evaluate the efficacy and outcomes of three different percutaneous transluminal angioplasty (PTA) approaches in the treatment of patients with arteriovenous fistula (AVF) dysfunction.
METHODS: A retrospective review was performed in a total of 183 patients with AVF dysfunction treated with 3 different PTA approaches (transarterial, transvenous and combination) in our hospital from October 2006 to October 2012. Technical and clinical success rate, complications and vessel patency were assessed.
RESULTS: The mean length of pretreatment stenosis segment was 2.0±1.4 cm (range 0.5-6.8 cm), and the mean length of stenosis segment was shortest in transvenous group. The technical success rates using transarterial and transvenous approach were 80.4% (P<0.01) and 87.8% (P<0.01), respectively, compared to 32.4% of combination approach. Moreover, the clinical success rates using transarterial and transvenous approach were 92.8% and 95.9% (P<0.01), respectively, comparing to 54.1% of combination approach. Moreover, significant difference was found on the presence of vasospasm among the three groups (P<0.01). In addition, a higher primary patency rate was also achieved by using transarterial (P<0.01) and transvenous approach (P<0.01) compared to combination approach.
CONCLUSIONS: Transarterial and transvenous PTA is more efficient than combination PTA for the patients with dysfunctional AVF. A high technical and clinical success rate could be achieved by using both approaches. Limited number of complications and high rate of primary patency were found in the patients.

inizio pagina